Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Synagile |
Description | SynAgile is developing DopaFuse® , the first patient-friendly, non-invasive therapy for continuous About Us Executive Team Board of Directors DopaFuse Parkinson’s Disease How it Works Clinical Trials FAQs Technology News Contact Us SynAgile is developin |
Keywords | N/A |
WebSite | synagile.com |
Host IP | 50.63.8.0 |
Location | United States |
Site | Rank |
US$2,979,408
Last updated: 2023-05-17 20:56:40
synagile.com has Semrush global rank of 3,552,486. synagile.com has an estimated worth of US$ 2,979,408, based on its estimated Ads revenue. synagile.com receives approximately 343,778 unique visitors each day. Its web server is located in United States, with IP address 50.63.8.0. According to SiteAdvisor, synagile.com is safe to visit. |
Purchase/Sale Value | US$2,979,408 |
Daily Ads Revenue | US$2,751 |
Monthly Ads Revenue | US$82,507 |
Yearly Ads Revenue | US$990,080 |
Daily Unique Visitors | 22,919 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
synagile.com. | A | 600 | IP: 50.63.8.0 |
synagile.com. | NS | 3600 | NS Record: ns51.domaincontrol.com. |
synagile.com. | NS | 3600 | NS Record: ns52.domaincontrol.com. |
synagile.com. | MX | 1800 | MX Record: 10 ALT3.ASPMX.L.GOOGLE.com. |
synagile.com. | MX | 1800 | MX Record: 10 ALT4.ASPMX.L.GOOGLE.com. |
synagile.com. | MX | 1800 | MX Record: 1 ASPMX.L.GOOGLE.com. |
synagile.com. | MX | 1800 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.com. |
synagile.com. | MX | 1800 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.com. |
synagile.com. | TXT | 1800 | TXT Record: v=spf1 include:_spf.google.com ~all |
synagile.com. | TXT | 1800 | TXT Record: google-site-verification=0jkCnU0oS_uAaQtihffzq_0hWfM7Y8LGuuD_cDs_BrA |
About Us Executive Team Board of Directors DopaFuse Parkinson’s Disease How it Works Clinical Trials FAQs Technology News Contact Us SynAgile is developing DopaFuse ® , the first patient-friendly, non-invasive therapy for continuous delivery of levodopa and carbidopa About DopaFuse Designed for Parkinson’s Disease patients Provides continuous delivery of levodopa May provide more stable drug levels in the blood, potentially reducing "Off" time Uses the OraFuse platform About OraFuse ® OraFuse is SynAgile’s proprietary technology for continuous drug delivery in the mouth Can be used for numerous drugs OraFuse Technology: A novel, non-invasive method of drug delivery in the mouth Drug Types Orally-delivered drugs, including: Narrow therapeutic index drugs. Drugs that cannot be formulated for extended release Buccally-delivered drugs Topical drugs for the mouth, pharynx, and esophagus Benefits More stable plasma drug concentrations. Fewer dose-related side effects. Allows buccal delivery |
HTTP/1.1 302 Found Date: Wed, 20 Apr 2022 09:06:46 GMT Server: Apache Location: https://www.synagile.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 last-modified: Sun, 13 Feb 2022 04:28:00 GMT etag: "c1a02eb-3a06-5d7deb99e467a" accept-ranges: bytes content-length: 14854 vary: Accept-Encoding content-type: text/html date: Wed, 20 Apr 2022 09:06:47 GMT server: Apache |
Domain Name: SYNAGILE.COM Registry Domain ID: 1694758666_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-01-01T17:02:47Z Creation Date: 2011-12-31T19:21:41Z Registry Expiry Date: 2023-12-31T19:21:41Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS51.DOMAINCONTROL.COM Name Server: NS52.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-04-20T09:29:01Z <<< |